Masters Pharmaceutical, Inc.
Masters Pharmaceutical, Inc., commonly referred to as MastersRx, is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2003, the company has established a strong presence in key operational regions across North America, focusing on the development and distribution of high-quality pharmaceutical products. Specialising in generic and specialty medications, MastersRx is recognised for its commitment to innovation and quality assurance. The company’s core offerings include a diverse range of prescription medications that cater to various therapeutic areas, setting them apart through rigorous testing and compliance with industry standards. With a reputation for reliability and excellence, Masters Pharmaceutical has achieved significant milestones, positioning itself as a trusted partner in healthcare. Their dedication to improving patient outcomes and enhancing access to essential medications underscores their notable achievements in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Masters Pharmaceutical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Masters Pharmaceutical, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Masters Pharmaceutical, Inc.'s reported carbon emissions
Masters Pharmaceutical, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no emissions figures, including Scope 1, 2, or 3 emissions, to report. In the absence of specific data, it is important to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate commitments. This includes setting ambitious targets for reducing greenhouse gas emissions and improving energy efficiency. However, without concrete data or commitments from Masters Pharmaceutical, Inc., it is unclear how they align with these industry trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Masters Pharmaceutical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
